UBC Medical Indonesia (LABS.JK) Earnings Analysis
UBC Medical Indonesia (LABS.JK) has no confirmed upcoming earnings date. Trailing P/E 49.68.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does LABS.JK next report earnings?
No confirmed upcoming earnings date is currently scheduled for LABS.JK. This page updates as the calendar is published.
LABS.JK earnings history — beats and misses
No reported earnings history is available for this symbol in our dataset.
LABS.JK valuation and analyst view
| Trailing P/E | 49.68 |
|---|---|
| Trailing EPS | 2.043 IDR |
| Price / book | 5.80 |
| Dividend yield | 0.00% |
| Market cap | 580.65B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is UBC Medical Indonesia (LABS.JK)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for LABS.JK. This page updates as the calendar is published.
What is LABS.JK's current P/E ratio and EPS?
LABS.JK trades at a trailing P/E of 49.68 on trailing EPS of 2.0430822323706086 IDR.
What do analysts rate LABS.JK?
LABS.JK has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.